Research based on cherry-picking statistics and small studies suited the needs of the pharmaceutical industry, but it may have been all wrong.

Increasing evidence suggests an interplay between the gut microbiome and nonalcoholic fatty liver disease (NAFLD). The role of the microbiome in the early detection of the condition remains unclear.

This is the 9th article in a series on America’s dysfunctional healthcare system

How dangerous is Gain of Function research really and what risks does it pose to us for future pandemics. We explore this branch of science and examine